Systemic Immunotherapy for the Treatment of Brain Metastases

被引：60

作者：

Cohen, Justine V. ^{[1
]}

Kluger, Harriet M. ^{[1
]}

机构：

[1] Yale Canc Ctr, Dept Med, Sect Med Oncol, New Haven, CT USA

来源：

FRONTIERS IN ONCOLOGY | 2016年 / 6卷

关键词：

immunotherapy; brain metastases; melanoma; CENTRAL NERVOUS-SYSTEM; MELANOMA PATIENTS; ANTI-PD-L1; ANTIBODY; CLINICAL ACTIVITY; OPEN-LABEL; CHECKPOINT BLOCKADE; RADIATION-THERAPY; IPILIMUMAB; SAFETY; EFFICACY;

D O I：

10.3389/fonc.2016.00049

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 58 条

[41] Ipilimumab and radiation therapy for melanoma brain metastases [J].

Silk, Ann W. ;

Bassetti, Michael F. ;

West, Brady T. ;

Tsien, Christina I. ;

Lao, Christopher D. .

CANCER MEDICINE, 2013, 2 (06) :899-906

[42] Safety of Bevacizumab in Patients With Non-Small-Cell Lung Cancer and Brain Metastases [J].

Socinski, Mark A. ;

Langer, Corey J. ;

Huang, Jane E. ;

Kolb, Margaret M. ;

Compton, Peter ;

Wang, Lisa ;

Akerley, Wallace .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) :5255-5261

[43] Determinants of survival in patients with brain metastases from cutaneous melanoma [J].

Staudt, M. ;

Lasithiotakis, K. ;

Leiter, U. ;

Meier, F. ;

Eigentler, T. ;

Bamberg, M. ;

Tatagiba, M. ;

Brossart, P. ;

Garbe, C. .

BRITISH JOURNAL OF CANCER, 2010, 102 (08) :1213-1218

[44]

STEWART DJ, 1984, J NEURO-ONCOL, V2, P133

[45]

STEWART DJ, 1982, CANCER RES, V42, P2474

[46]

Tabernero J, 2013, J CLIN ONCOL, V31, P3622

[47] Stereotactic laser induced thermotherapy (LITT): a novel treatment for brain lesions regrowing after radiosurgery [J].

Torres-Reveron, Juan ;

Tomasiewicz, Hilarie C. ;

Shetty, Anil ;

Amankulor, Nduka M. ;

Chiang, Veronica L. .

JOURNAL OF NEURO-ONCOLOGY, 2013, 113 (03) :495-503

[48] Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer [J].

Twyman-Saint Victor, Christina ;

Rech, Andrew J. ;

Maity, Amit ;

Rengan, Ramesh ;

Pauken, Kristen E. ;

Stelekati, Erietta ;

Benci, Joseph L. ;

Xu, Bihui ;

Dada, Hannah ;

Odorizzi, Pamela M. ;

Herati, Ramin S. ;

Mansfield, Kathleen D. ;

Patsch, Dana ;

Amaravadi, Ravi K. ;

Schuchter, Lynn M. ;

Ishwaran, Hemant ;

Mick, Rosemarie ;

Pryma, Daniel A. ;

Xu, Xiaowei ;

Feldman, Michael D. ;

Gangadhar, Tara C. ;

Hahn, Stephen M. ;

Wherry, E. John ;

Vonderheide, Robert H. ;

Minn, Andy J. .

NATURE, 2015, 520 (7547) :373-+

[49] A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma [J].

Weber, Jeffrey ;

Thompson, John A. ;

Hamid, Omid ;

Minor, David ;

Amin, Asim ;

Ron, Ilan ;

Ridolfi, Ruggero ;

Assi, Hazem ;

Maraveyas, Anthony ;

Berman, David ;

Siegel, Jonathan ;

O'Day, Steven J. .

CLINICAL CANCER RESEARCH, 2009, 15 (17) :5591-5598

[50] Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial [J].

Weber, Jeffrey S. ;

D'Angelo, Sandra P. ;

Minor, David ;

Hodi, F. Stephen ;

Gutzmer, Ralf ;

Neyns, Bart ;

Hoeller, Christoph ;

Khushalani, Nikhil I. ;

Miller, Wilson H., Jr. ;

Lao, Christopher D. ;

Linette, Gerald P. ;

Thomas, Luc ;

Lorigan, Paul ;

Grossmann, Kenneth F. ;

Hassel, Jessica C. ;

Maio, Michele ;

Sznol, Mario ;

Ascierto, Paolo A. ;

Mohr, Peter ;

Chmielowski, Bartosz ;

Bryce, Alan ;

Svane, Inge M. ;

Grob, Jean-Jacques ;

Krackhardt, Angela M. ;

Horak, Christine ;

Lambert, Alexandre ;

Yang, Arvin S. ;

Larkin, James .

LANCET ONCOLOGY, 2015, 16 (04) :375-384

← 1 2 3 4 5 6 →